Navigation Links
NutraCea Appoints Financial Relations Board as New Investor Relations Firm

PHOENIX, Oct. 24 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a health science company and a world leader in stabilized rice bran (SRB) nutrient research and technology whose products include food supplements and medical foods, which provide health benefits for humans and animals announced today that it has retained the Financial Relations Board (FRB) for investor relations services and an expanded communications program among the investment community.

"We believe that 2008 will represent an important chapter in the growth of our company both domestically and internationally. We're pleased to be working with such a high caliber firm as FRB to communicate our story to the investment community," said Margie Adelman, Senior Vice President NutraCea.

"FRB is a well-established leader in the investor relations practice and we have engaged them to assist us in appropriately communicating our achievements and prospects and building our relationships with the investment community. We look forward to the visibility for NutraCea that this relationship will help to create, "added Adelman.

Claire Koeneman, Co-President of the Financial Relations Board, stated, "We are most pleased to have added NutraCea to the FRB practice and look forward to working with them to gain further recognition for the company within the investment community."

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site

About Financial Relations Board

For more than 40 years, the Financial Relations Board has been one of the nation's leaders for investor relations and financial communications. The firm offers a full array of services including deep expertise in corporate positioning and communication, investment community targeting (market intelligence), financial media relations, shareholder management services, valuation analysis and the company's industry-leading Strategy Consulting Group. Financial Relations Board works alongside companies of all sizes, from established Fortune 100 brands to mid-size and micro-cap companies, pre-IPOs and the newly public. Headquartered in Chicago, the firm has full-service offices in New York, Los Angeles, San Francisco and Washington, D.C. Financial Relations Board is part of the Interpublic Group of Companies (NYSE: IPG). For more information on Financial Relations Board, visit

Forward Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding the future communications with the investment community regarding NutraCea. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.

Company Contact:

Margie Adelman

Senior V.P. NutraCea


916-220-3500 cell

Investor Relations Contact:

Marilyn Meek

Financial Relations Board


Julie Tu

Financial Relations Board


Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
2. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
3. Health conditions and patient treatment affected by a financial crunch
4. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
5. Bird Flu: Fear of the Unknown Could Put Financial Markets in a Soup
6. Huge financial losses due to Bird flu scare!
7. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
8. Elective Surgery - the Financial Whipping Boy
9. British Hospitals Face Financial Crisis
10. Kidney donors do not realize financial gains
11. Bird-Flu Pandemic will be a Huge Financial Drain, says World Bank
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: